Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionJacobs & Co/ca
Latest Disclosed Ownership43,121 shares
Latest Disclosed Value $ 15,172
Jacobs & Co/ca reports 1.05% decrease in ownership of AMGN / Amgen Inc.

On April 7, 2026 - Jacobs & Co/ca filed a 13F-HR form disclosing ownership of 43,121 shares of Amgen Inc. (MX:AMGN) valued at $15,172 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 5, 2026 disclosing 43,579 shares of Amgen Inc.. This represents a change in shares of -1.05% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F Amgen COM 031162100 43,121 -458 -1.05 15 7.14 1.4974
2026-01-05 2025-12-31 13F AmgenIncorporated COM 031162100 43,579 -1,480 -3.28 14 16.67 1.3460
2025-10-01 2025-09-30 13F Amgen COM 031162100 45,059 1,078 2.45 13 0.00 1.2164
2025-07-02 2025-06-30 13F Amgen COM 031162100 43,981 62 0.14 12 -7.69 1.2184
2025-04-03 2025-03-31 13F AmgenIncorporated COM 031162100 43,919 -237 -0.54 14 18.18 1.4586
2025-01-10 2024-12-31 13F AmgenIncorporated COM 031162100 44,156 78 0.18 12 -21.43 1.1708
2024-10-01 2024-09-30 13F Amgen COM 031162100 44,078 -812 -1.81 14 0.00 1.4201
2024-07-12 2024-06-30 13F Amgen COM 031162100 44,890 -363 -0.80 14 16.67 1.4700
2024-04-12 2024-03-31 13F AmgenIncorporated COM 031162100 45,253 -1 -0.00 13 -7.69 1.3620
2024-01-18 2023-12-31 13F AmgenIncorporated COM 031162100 45,254 -739 -1.61 13 8.33 1.4784
2023-10-13 2023-09-30 13F AmgenIncorporated COM 031162100 45,993 -894 -1.91 12 20.00 1.5404
2023-07-11 2023-06-30 13F Amgen COM 031162100 46,887 726 1.57 10 -9.09 1.2377
2023-04-17 2023-03-31 13F Amgen COM 031162100 46,161 89 0.19 11 -8.33 1.3777
2023-01-13 2022-12-31 13F Amgen COM 031162100 46,072 -719 -1.54 12 -99.89 1.5749
2022-10-11 2022-09-30 13F Amgen COM 031162100 46,791 -2 -0.00 10,546 -7.36 1.5161
2022-07-19 2022-06-30 13F Amgen COM 031162100 46,793 -873 -1.83 11,384 -1.23 1.5245
2022-04-14 2022-03-31 13F Amgen COM 031162100 47,666 192 0.40 11,526 7.92 1.2762
2022-01-21 2021-12-31 13F Amgen COM 031162100 47,474 1,452 3.16 10,680 9.14 1.1074
2021-10-13 2021-09-30 13F Amgen COM 031162100 46,022 5,064 12.36 9,786 -1.97 1.1256
2021-07-15 2021-06-30 13F Amgen COM 031162100 40,958 2,054 5.28 9,983 3.14 1.1531
2021-04-05 2021-03-31 13F Amgen COM 031162100 38,904 292 0.76 9,679 9.03 1.1829
2021-01-12 2020-12-31 13F Amgen COM 031162100 38,612 203 0.53 8,877 -9.07 1.1530
2020-12-03 2020-09-30 13F Amgen COM 031162100 38,409 -232 -0.60 9,762 7.12 1.4163
2020-07-09 2020-06-30 13F Amgen COM 031162100 38,641 -1,438 -3.59 9,113 12.16 1.4832
2020-04-13 2020-03-31 13F Amgen COM 031162100 40,079 505 1.28 8,125 -14.83 1.5682
2020-01-29 2019-12-31 13F Amgen COM 031162100 39,574 655 1.68 9,540 26.68 1.4492
2019-11-04 2019-09-30 13F Amgen COM 031162100 38,919 -500 -1.27 7,531 3.68 1.2213
2019-08-01 2019-06-30 13F Amgen COM 031162100 39,419 234 0.60 7,264 -2.42 1.1724
2019-04-29 2019-03-31 13F Amgen COM 031162100 39,185 0 0.00 7,444 -2.41 1.2678
2019-02-07 2018-12-31 13F Amgen COM 031162100 39,185 -669 -1.68 7,628 -7.66 1.5034
2018-10-23 2018-09-30 13F Amgen COM 031162100 39,854 -1,339 -3.25 8,261 8.65 1.3969
2018-07-19 2018-06-30 13F Amgen COM 031162100 41,193 1,441 3.62 7,603 12.20 1.3768
2018-04-27 2018-03-31 13F Amgen COM 031162100 39,752 175 0.44 6,776 -0.94 1.2514
2018-02-09 2017-12-31 13F Amgen COM 031162100 39,577 -662 -1.65 6,840 -8.82 1.2361
2017-11-14 2017-09-30 13F Amgen COM 031162100 40,239 -114 -0.28 7,502 7.94 1.4104
2017-07-13 2017-06-30 13F Amgen COM 031162100 40,353 -7 -0.02 6,950 4.97 1.3685
2017-04-12 2017-03-31 13F Amgen COM 031162100 40,360 -456 -1.12 6,621 10.96 1.3606
2017-01-18 2016-12-31 13F Amgen COM 031162100 40,816 2,230 5.78 5,967 -7.29 1.2942
2016-10-11 2016-09-30 13F Amgen COM 031162100 38,586 803 2.13 6,436 11.97 1.4351
2016-07-08 2016-06-30 13F Amgen COM 031162100 37,783 2,270 6.39 5,748 7.96 1.3503
2016-04-14 2016-03-31 13F Amgen COM 031162100 35,513 356 1.01 5,324 0.43 1.2812
2016-01-14 2015-12-31 13F Amgen COM 031162100 35,157 1,607 4.79 5,301 14.25 1.3731
2015-10-15 2015-09-30 13F Amgen COM 031162100 33,550 1,426 4.44 4,640 -5.90 1.2322
2015-07-02 2015-06-30 13F Amgen COM 031162100 32,124 -234 -0.72 4,931 -4.68 1.2342
2015-04-07 2015-03-31 13F Amgen COM 031162100 32,358 277 0.86 5,173 1.23 1.3101
2015-03-10 2014-12-31 13F Amgen COM 031162100 32,081 2,116 7.06 5,110 21.41 1.3453
2014-10-07 2014-09-30 13F Amgen COM 031162100 29,965 203 0.68 4,209 19.47 1.1904
2014-07-16 2014-06-30 13F/A-1 Amgen COM 031162100 29,762 -26 -0.09 3,523 -4.11 1.0210
2014-07-15 2014-06-30 13F Amgen COM 031162100 29,762 3,523
2014-04-22 2014-03-31 13F Amgen COM 031162100 29,788 0 0.00 3,674 8.12 1.1396
2014-01-27 2013-12-31 13F Amgen COM 031162100 29,788 -164 -0.55 3,398 1.37 1.0875
2013-10-09 2013-09-30 13F Amgen COM 031162100 29,952 -550 -1.80 3,352 11.40 1.1656
2013-07-19 2013-06-30 13F Amgen COM 031162100 30,502 30,502 3,009 1.0904
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.